ESR1 and breast carcinoma: In another study on breast cancer tissue specimens, Müller and colleagues reported an association between MeCP2 and estrogen receptor (ER), with higher MeCP2 levels in estrogen receptor (OR)-positive breast cancer samples compared to OR-negative ones [96].